News
US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms through the Biomedical Advanced Research and Development Authority, the agency ...
Health and Human Services Secretary Robert F. Kennedy Jr. has canceled $500 million in vaccine development after “listening ...
That kind of shot was first used during the Covid-19 pandemic, but the health secretary has been sharply critical of the ...
The Department of Health and Human Services plans to cancel contracts and pull funding for some vaccines being developed to ...
HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...
President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, ...
The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being ...
Pfizer Q2 2025 earnings show 10% revenue growth, raised EPS guidance, strong R&D, and operational execution. Explore growth drivers and policy risks.
In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results